Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Sep-24 4:04 PM View:  | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 20-Sep-24 | Purchase | 350,000 | $20.01 | $7,003,760.00 | 17% 2.02M to 2.38M | |
| 20-Aug-24 4:48 PM View: | Kung Winston Director | Corbus Pharmaceuticals Hold... (CRBP) | 16-Aug-24 | Grant | 5,566 | -- | -- | 100% 0 to 5.57K | |
| 18-Jun-24 5:59 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 18-Jun-24 | Option Exercise | 1,958 | $30.00 | $58,740.00 | 4% 48.6K to 50.56K | |
| 18-Jun-24 5:59 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 18-Jun-24 | Planned Option Sale | 1,958 | $42.12 | $82,479.20 | (4%) 50.56K to 48.6K | |
| 18-Jun-24 5:58 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 18-Jun-24 | Sale (Planned) | 7,179 | $42.24 | $303,219.00 | (9%) 84.4K to 77.22K | |
| 18-Jun-24 5:58 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 18-Jun-24 | Option Exercise | 15,759 | $24.42 | $384,859.00 | 19% 84.4K to 100.16K | |
| 18-Jun-24 5:58 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 18-Jun-24 | Planned Option Sale | 15,759 | $42.24 | $665,613.00 | (16%) 100.16K to 84.4K | |
| 18-Jun-24 5:58 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 17-Jun-24 | Option Exercise | 11,103 | $25.90 | $287,530.00 | 13% 84.4K to 95.5K | |
| 18-Jun-24 5:58 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 17-Jun-24 | Planned Option Sale | 11,103 | $46.02 | $510,963.00 | (12%) 95.5K to 84.4K | |
| 18-Jun-24 5:59 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-Jun-24 | Option Exercise | 6,730 | $14.10 | $94,893.00 | 14% 48.6K to 55.34K | |
| 18-Jun-24 5:59 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-Jun-24 | Planned Option Sale | 6,730 | $46.77 | $314,789.00 | (12%) 55.34K to 48.6K | |
| 18-Jun-24 5:58 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 14-Jun-24 | Option Exercise | 29,317 | $9.91 | $290,498.00 | 35% 84.4K to 113.72K | |
| 18-Jun-24 5:58 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 14-Jun-24 | Planned Option Sale | 29,317 | $50.17 | $1,470,720.00 | (26%) 113.72K to 84.4K | |
| 18-Jun-24 5:59 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 14-Jun-24 | Option Exercise | 9,355 | $8.57 | $80,186.90 | 19% 48.6K to 57.96K | |
| 18-Jun-24 5:59 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 14-Jun-24 | Planned Option Sale | 9,355 | $49.87 | $466,569.00 | (16%) 57.96K to 48.6K | |
| 14-Jun-24 4:24 PM View: | Holmer Alan F Director | Corbus Pharmaceuticals Hold... (CRBP) | 14-Jun-24 | Option Exercise | 1,667 | $30.00 | $50,010.00 | 40% 4.16K to 5.83K | |
| 03-Jun-24 4:29 PM View: | Jacques Rachelle Suzanne Director | Corbus Pharmaceuticals Hold... (CRBP) | 30-May-24 | Grant | 2,783 | -- | -- | 100% 0 to 2.78K | |
| 03-Jun-24 4:30 PM View: | Salzmann Peter Director | Corbus Pharmaceuticals Hold... (CRBP) | 30-May-24 | Grant | 2,783 | -- | -- | 100% 0 to 2.78K | |
| 03-Jun-24 4:26 PM View: | Altmeyer Anne Director | Corbus Pharmaceuticals Hold... (CRBP) | 30-May-24 | Grant | 2,783 | -- | -- | 100% 0 to 2.78K | |
| 03-Jun-24 4:27 PM View: | Holmer Alan F Director | Corbus Pharmaceuticals Hold... (CRBP) | 30-May-24 | Grant | 2,783 | -- | -- | 202% 1.38K to 4.16K | |
| 03-Jun-24 4:32 PM View: | Jenkins John Kenneth Director | Corbus Pharmaceuticals Hold... (CRBP) | 30-May-24 | Grant | 2,783 | -- | -- | 8433% 33 to 2.82K | |
| 03-Jun-24 4:28 PM View: | Ben Yong Director | Corbus Pharmaceuticals Hold... (CRBP) | 30-May-24 | Grant | 2,783 | -- | -- | 100% 0 to 2.78K | |
| 03-Jun-24 4:31 PM View: | Catlin Avery W Director | Corbus Pharmaceuticals Hold... (CRBP) | 30-May-24 | Grant | 2,783 | -- | -- | 178% 1.57K to 4.35K | |
| 11-Apr-24 9:17 AM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Apr-24 | Option Exercise | 1,787 | $30.00 | $53,610.00 | 4% 46.82K to 48.6K | |
| 11-Mar-24 5:34 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 08-Mar-24 | Purchase | 300,000 | $44.38 | $13,314,200.00 | 17% 1.73M to 2.02M | |
| 11-Mar-24 5:34 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 07-Mar-24 | Purchase | 250,000 | $40.05 | $10,013,400.00 | 17% 1.48M to 1.73M | |
| 29-Feb-24 5:13 PM View: | Smethurst Dominic Chief Medical Officer | Corbus Pharmaceuticals Hold... (CRBP) | 27-Feb-24 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 14-Feb-24 3:19 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 12-Feb-24 | Grant | 73,947 | -- | -- | 707% 10.45K to 84.4K | |
| 14-Feb-24 3:26 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 12-Feb-24 | Grant | 40,176 | -- | -- | 605% 6.64K to 46.82K | |
| 06-Feb-24 4:00 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 02-Feb-24 | Purchase | 750,000 | $19.00 | $14,250,000.00 | 103% 725.0K to 1.48M | |
| 30-Jan-24 4:23 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 26-Jan-24 | Purchase | 282,632 | $32.24 | $9,111,940.00 | 64% 442.37K to 725.0K | |
| 30-Jan-24 6:07 PM View: | Holmer Alan F Director | Corbus Pharmaceuticals Hold... (CRBP) | 26-Jan-24 | Option Exercise | 629 | $4.97 | $3,126.13 | 84% 0.75K to 1.38K | |
| 30-Jan-24 4:56 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 26-Jan-24 | Option Exercise | 7,179 | $4.97 | $35,679.60 | 100% 0 to 7.18K | |
| 12-Aug-22 9:43 AM View: | Millian Craig Stuart Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Aug-22 | Private Purchase | 5,000 | $0.25 | $1,272.50 | 23% 22.0K to 27.0K | |
| 11-Aug-22 9:55 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 10-Aug-22 | Private Purchase | 3,800 | $0.26 | $1,003.20 | 4% 94.43K to 98.23K | |
| 10-Aug-22 10:16 AM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Aug-22 | Private Purchase | 20,000 | $0.26 | $5,198.00 | 11% 179.27K to 199.27K | |
| 16-May-22 11:03 AM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 16-May-22 | Private Purchase | 12,000 | $0.30 | $3,600.00 | 7% 167.27K to 179.27K | |
| 16-May-22 10:41 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 16-May-22 | Private Purchase | 10,500 | $0.25 | $2,625.00 | 13% 83.93K to 94.43K | |
| 10-Mar-22 11:47 AM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Mar-22 | Private Purchase | 15,000 | $0.37 | $5,550.00 | 10% 152.27K to 167.27K | |
| 11-Mar-22 11:23 AM View: | Millian Craig Stuart Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Mar-22 | Private Purchase | 10,000 | $0.37 | $3,700.00 | 83% 12.0K to 22.0K | |
| 09-Mar-22 10:37 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 09-Mar-22 | Private Purchase | 8,600 | $0.37 | $3,182.00 | 11% 75.33K to 83.93K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 21-Dec-20 | Planned Option Sale | 87,500 | $1.75 | $153,125.00 | (20%) 437.11K to 349.61K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 21-Dec-20 | Option Exercise | 87,500 | $1.40 | $122,500.00 | 25% 349.61K to 437.11K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 18-Dec-20 | Planned Option Sale | 53,610 | $1.40 | $75,054.00 | (13%) 403.22K to 349.61K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 18-Dec-20 | Option Exercise | 53,610 | $1.00 | $53,610.00 | 15% 349.61K to 403.22K | |
| 18-Dec-20 4:44 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 16-Dec-20 | Option Exercise | 36,923 | $0.17 | $6,118.14 | 11% 349.61K to 386.53K | |
| 18-Dec-20 4:44 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 16-Dec-20 | Planned Option Sale | 36,923 | $1.32 | $48,627.60 | (10%) 386.53K to 349.61K | |
| 12-Nov-20 10:28 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 11-Nov-20 | Private Purchase | 4,240 | $1.21 | $5,126.16 | 6% 71.09K to 75.33K | |
| 18-Mar-20 11:21 AM View: | Discordia Robert Paul Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-Mar-20 | Private Purchase | 2,840 | $3.54 | $10,053.60 | 9% 32.65K to 35.49K | |
| 18-Mar-20 1:18 PM View: | Millian Craig Stuart Chief Commercial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-Mar-20 | Private Purchase | 2,000 | $4.25 | $8,500.00 | 20% 10.0K to 12.0K |
